Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Jerusalem

Showing results (51-60 of 89) with videos related to

Pageof 9
Sort By:
European Journal of Cancer Care|September 30, 2017
Communication of healthcare professionals: Is there ageism?S Schroyen, S Adam, M Marquet, et al.
Revue Medicale De Liege|April 29, 2004
[Image of the month. Merkel cell tumor: response to chemotherapy]M Polus, P Piront, G Jerusalem, et al.
Blood|July 9, 1999
Whole-body positron emission tomography using 18F-fluorodeoxyglucose for posttreatment evaluation in Hodgkin's disease and non-Hodgkin's lymphoma has higher diagnostic and prognostic value than classical computed tomography scan imagingG Jerusalem, Y Beguin, M F Fassotte, et al.
Revue Medicale De Liege|March 13, 2010
[Hypofractionated postoperative radiotherapy for breast cancer]P A Coucke, N Jansen, J Collignon, et al.
Revue Medicale De Liege|April 7, 2017
[Cancer therapy-induced cardiotoxicity]P Frères, A Poncin, M Moonen, et al.
Revue Medicale De Liege|August 1, 2009
[Monoclonal antibodies and breast cancer. Current therapeutic progress]J Collignon, C Gennigens, A Rorive, et al.
Revue Medicale De Liege|August 11, 2011
[Systemic chemotherapy and breast cancer]J Collignon, A Rorive, M Martin, et al.
Revue Medicale De Liege|August 11, 2011
[Targeted therapies in breast cancer]G Jerusalem, J Collignon, A Rorive, et al.
Revue Medicale De Liege|August 11, 2011
[Breast cancer in young women]C André, J Collignon, A Rorive, et al.
ESMO Open|September 15, 2022
Recurrent or primary metastatic cervical cancer: current and future treatmentsC Gennigens, G Jerusalem, L Lapaille, et al.
Pageof 9

Showing results (51-60 of 89) with videos related to

Sort By:
Pageof 9
European Journal of Cancer Care|September 30, 2017
Communication of healthcare professionals: Is there ageism?S Schroyen, S Adam, M Marquet, et al.
Revue Medicale De Liege|April 29, 2004
[Image of the month. Merkel cell tumor: response to chemotherapy]M Polus, P Piront, G Jerusalem, et al.
Blood|July 9, 1999
Whole-body positron emission tomography using 18F-fluorodeoxyglucose for posttreatment evaluation in Hodgkin's disease and non-Hodgkin's lymphoma has higher diagnostic and prognostic value than classical computed tomography scan imagingG Jerusalem, Y Beguin, M F Fassotte, et al.
Revue Medicale De Liege|March 13, 2010
[Hypofractionated postoperative radiotherapy for breast cancer]P A Coucke, N Jansen, J Collignon, et al.
Revue Medicale De Liege|April 7, 2017
[Cancer therapy-induced cardiotoxicity]P Frères, A Poncin, M Moonen, et al.
Revue Medicale De Liege|August 1, 2009
[Monoclonal antibodies and breast cancer. Current therapeutic progress]J Collignon, C Gennigens, A Rorive, et al.
Revue Medicale De Liege|August 11, 2011
[Systemic chemotherapy and breast cancer]J Collignon, A Rorive, M Martin, et al.
Revue Medicale De Liege|August 11, 2011
[Targeted therapies in breast cancer]G Jerusalem, J Collignon, A Rorive, et al.
Revue Medicale De Liege|August 11, 2011
[Breast cancer in young women]C André, J Collignon, A Rorive, et al.
ESMO Open|September 15, 2022
Recurrent or primary metastatic cervical cancer: current and future treatmentsC Gennigens, G Jerusalem, L Lapaille, et al.
Pageof 9